Peter J. Blankestijn

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi, Roland E. Schmieder, Felix Mahfoud et al. · The Lancet · 2018 · 716 citations · Full text

Medicine, Cardiology, Nephrology +14

Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes

Muriël P.C. Grooteman, Marinus A. van den Dorpel, Michiel L. Bots et al. · Journal of the American Society of Nephrology · 2012 · 519 citations · Full text

Medicine, Hematology, Nephrology +10

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

Bakhtawar K. Mahmoodi, Kunihiro Matsushita, Mark Woodward et al. · The Lancet · 2012 · 444 citations · Full text

Medicine, Internal Medicine, Nephrology +14

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Christopher T. Chan, Peter J. Blankestijn, Laura M. Dember et al. · Kidney International · 2019 · 420 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure

Gerry Ligtenberg, Peter J. Blankestijn, P. Liam Oey et al. · New England Journal of Medicine · 1999 · 408 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17